Innovative technology based on phages and data, developed to eliminate specific bacteria.
Our production process is carried out according to pharmaceutical quality standards with exceptional yields.
Our production process is carried out according to pharmaceutical quality standards with exceptional yields.
Our team of real-time PCR and WGS specialists can process our clients’ samples, sequence DNA libraries, and identify the problematic bacteria in 25 days. We implement new technologies, processes, and top-level team players to generate comprehensive profiles of target bacteria.
Our team of bioinformaticians with extensive computational biology, genomics, and data science experience reduced the time of analysis from 12 months to 10 hours through new scripts, parallelization, and automation.
In this step, the team isolates and characterizes the genomics, kinetic parameters, and physicochemical properties of new phages. Using the double-layer agar technique they test the phages with the potential to interact with the problem bacteria from a client. We have a huge library of characterized bacteriophages.
Our AI team developed proprietary pipelines that accurately predict the target bacteria’s lytic susceptibility against a phage. These workflows help us select the best candidates for a phage cocktail. To that end, our team characterizes the bacteria’s genome, the phage’s genome, and historical data detailing interactions between phages and bacteria.
The best-performing phages are next tested through quantitative assays against the client’s bacterial collection. The designed cocktails are evaluated quantitatively in vitro, and the most effective phages in terms of lytic activity will compose the phage cocktail.
Our new cocktail prototypes are formulated to minimize modifications to our clients’ SOPs. The formulations consist of excipients that must meet the following criteria:
Our Manufacturing, Science & Technology team (MSAT) serves as the bridge between Development and Production. They are in charge of standardizing the optimal conditions to scale up the phages comprising a product.
This international team evaluates the efficacy of our products under real conditions as well as the productive parameters. They go wherever our clients are and assist in setting up the product implementation.
We house the first cost-efficient phage manufacturing facility in the world. Through our manufacturing team, we produce bacteriophage cocktails with immense scalability. Additionally, the yields we obtain with our liquid zootechnical additives allow us to administer them to millions of animals each year.
Our operations team ensures adherence to good manufacturing practices and other relevant standards by implementing and maintaining quality assurance systems at each development and production stage. Additionally, the team manages the logistics of transporting and distributing biotechnological products, ensuring timely delivery in compliance with transportation regulations.
NAVIGATING DIVERSE MARKETS WITH A DEDICATED TEAM OF SPECIALISTS
Our global regulatory affairs team makes sure that our products are approved by the regulatory authorities of each target market.
The use of phages as a technology to eliminate bacteria increases animal welfare and health. Additionally, it reduces the use of chemical products and other bactericides that alter and perturb animal and human microbiomes.
Our IP team performs diverse scouting activities across the organization to establish an IP strategy that protects the different developments and technologies created by our organization. We already have multiple granted patents across LatAm, Europe, and the US.
Our operations center, located in Santiago de Chile, consists of 4 floors of the UC Anacleto Angelini Innovation Center. A dynamic and collaborative space, with infrastructure and equipment with international standards.
Equipped with cutting-edge technology, our state-of-the-art laboratories seamlessly progress from diagnosis to the production of powerful bacteriophage solutions.
These high-tech facilities and equipment enable precise and effective operation throughout our processes.
Our multidisciplinary teams use these resources to drive breakthroughs, ensuring the effortless integration of science and technology within our advanced infrastructure.